Skip to main content

Table 4 Annual drug utilisation

From: Real-world costs of autosomal dominant polycystic kidney disease in the Nordics

Proportion (%) of patients using drug class, past 12 months

CKD 1–3 (n = 64)

CKD 4–5 (n = 55)

Dialysis (n = 61)

Transplant (n = 63)

P value

Antihypertensives

84

98

84

87

0.0275

Phosphate binders

0

21

95

14

<0.0001

ESAs

2

13

80

15

<0.0001

Analgesics for kidney paina

17

28

25

17

0.4149

Vitamin D analogsa

14

57

97

43

<0.0001

Immunosupressantsa

0

0

7

100

<0.0001

Other drugs

19

36

90

41

<0.0001

  1. P values calculated with Fisher’s exact test unless otherwise specified
  2. ESA Erythropoiesis-stimulating agent
  3. aχ2 test